EcoNomad raises £400K to bring waste-to-energy tech to small livestock farms

UK‑based startup EcoNomad Solutions has received £230,000 in funding from the British Design Fund (BDF) to help small livestock farms cut methane emissions, reduce rising energy and fertiliser costs, …

Efferon is ‘selling time’ in the race to treat sepsis

Every minute one person in Europe dies from sepsis or septic shock. Sepsis arises when the body’s response to an infection injures its own tissues and organs. It may lead to shock, multi-organ failure…

German biotech AquaNab secures funding to tackle sea lice with nanoantibodies

Hamburg-basedbiotechnology startup AquaNab has secured investment from Nordic Foodtech VC toadvance its nanoantibody platform for treating and preventing diseases inaquaculture. The investment marks t…

Clean Cells acquires Anaquant to expand biopharma quality control with mass spectrometry expertise

French biopharma quality control services provider Clean Cells today announces its acquisition of French company Anaquant, a specialist in mass-spectrometry-based bioanalysis. Founded in 2020, Clean C…

Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials

Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has raised $20 mil…

Dimension Capital’s $800M third fund shows the intersection of science and compute is booming

The four-year-old firm’s latest fund is 60% larger than its second vehicle announced 18 months ago.

Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform

Sightera Biosciences, a Belgiantechbio company using generative AI to develop novel small-molecule therapies,has raised €3 million in a pre-seed funding round led by Entourage, Anacura andQBIC.A spin-…

Aardaia bags €5M to build the next generation of crops

Aardaia, a Wageningen-based agritechstartup developing new crop varieties from wild plants, has raised €5 millionin a seed funding round led by Point Nine. Existing investor FoodLabsparticipated in th…

Roundtables: Longevity’s Next Frontier: “Reprogramming” Your Body

Listen to the session or watch below Billions of dollars are flooding into efforts to reverse aging as scientists explore ways to return cells to a younger state. But how far off are these experimental treatments? Will they really work? Watch a conversation exploring longevity’s new focus. Speakers: Mary Beth Griggs, science editor and Jessica…

Graph Therapeutics brings total funding to over $10M to advance precision immunology

Graph Therapeutics, a next-generation techbio company developing precision medicinesfor inflammatory and immune-mediated diseases, has secured a new $5 millioninvestment led by Daphni, the Paris-based…